查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1539298

經導管心臟瓣膜置換·修復市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2033年

Transcatheter Heart Valve Replacement Repair Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 231 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球經導管心臟瓣膜置換和修復 (TAVR) 市場的深入研究報告，詳細介紹了市場動態，包括驅動因素、趨勢、機會和課題。本報告旨在提供對市場結構和未來前景的全面了解，特別是心血管醫療器材產業的利害關係人。

主要的洞察

  • 全球市場收入（2022 年）：84 億美元
  • 預計市場價值（2033 年）：255 億美元
  • 全球市場成長率（2022-2033 年複合年增長率）：13.1%

TAVR 的全球市場 - 報告範圍：

TAVR 市場專注於用於更換和修復心臟瓣膜的設備和技術的生產和分銷，特別是用於患有嚴重主動脈瓣狹窄和其他心血管疾病的患者。該市場的推動因素包括心血管疾病的日益普及、微創手術的日益普及以及 TAVR 產品的持續技術進步。

推動市場成長的因素：

TAVR 產品技術不斷進步，心血管疾病盛行率不斷上升

TAVR 市場的關鍵驅動因素之一是經導管主動脈瓣置換 (TAVR) 設備的持續技術進步。該公司正在開發第二代、更耐用的 TAVR 設備，以減少嚴重主動脈瓣狹窄患者的免疫排斥反應。正如最近的幾項研究所證明的那樣，這些新設備具有顯著的安全優勢，包括降低瓣週逆流、瓣膜栓塞和其他出血事件的發生率。

先進的影像技術在改善 TAVR 手術期間的決策方面也發揮著重要作用。這些技術創新預計將為市場繁榮創造有利可圖的機會，持續的技術發展將推動 TAVI（經導管主動脈瓣植入術）和 TAVR 產品的未來成長。

心血管疾病（CVD）盛行率的上升是推動 TAVR 市場成長的另一個關鍵因素。據世界衛生組織 (WHO) 稱，心血管疾病是全球第一大死因，估計每年有 1,790 萬人死亡。由於心臟病發作和中風佔 CVD 死亡人數的五分之四以上，對 TAVR 等有效瓣膜置換手術的需求預計將增加，並成為市場擴張的驅動力。

市場課題

高成本與監理課題

儘管成長前景廣闊，但 TAVR 市場仍面臨一些課題。 TAVR 手術和設備的高成本可能是廣泛採用的主要障礙，特別是在醫療預算有限的低收入和中等收入國家。此外，TAVR 設備的監管環境很複雜，新產品上市前需要嚴格的審批流程。克服這些監管課題既耗時又昂貴，可能會減緩市場成長。

此外，雖然技術進步推動市場向前發展，但它們也需要大量的研發投資。公司必須不斷創新才能保持競爭力，這可能會導致資源緊張並影響獲利能力，特別是對於小市場中的公司。

本報告解決的關鍵問題

  • 推動全球 TAVR 市場成長的關鍵因素有哪些？
  • 哪些消費者群體正在推動 TAVR 的採用？
  • 技術進步如何影響競爭格局？
  • 誰是全球 TAVR 市場的主要參與者？
  • 全球 TAVR 市場的新趨勢和未來前景是什麼？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 蘊藏事項·除外事項

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品革新/開發趨勢

第4章 主要成功因素

  • 採用率/使用情形分析 - 各地區
  • 技術評估
  • 產品的USP分析
  • 法規情境
  • 疾病流行病學
  • 償付的形勢
  • 最近產品認證/銷售
  • PESTEL分析
  • 波特分析
  • 價值鏈分析

第5章 市場背景

  • 宏觀經濟要素
  • 預測要素 - 相關性及影響
  • 市場動態

第6章 COVID-19危機分析

  • COVID-19及影響分析
    • 各產品
    • 各適應症
    • 各終端用戶
    • 各地區
  • 2024年的市場情境

第7章 全球市場的需求(金額10億美元)分析

  • 過去的市場金額(10億美元)分析，2019年～2023年
  • 現在及未來市場金額(10億美元)的分析與預測，2024年～2033年
    • 與前一年同期比較成長趨勢分析
    • 絕對額的機會分析

第8章 全球市場分析:各產品

  • 簡介/主要調查結果
  • 過去的市場規模(10億美元)分析:各產品，2019年～2023年
  • 現在及未來市場規模(10億美元)的分析與預測:各產品，2024年～2033年
    • 經導管主動脈瓣置換術(TAVR)設備
    • 經導管二尖瓣瓣膜修復(TMVR)設備
  • 市場魅力分析:各產品

第9章 全球市場分析:各適應症

  • 簡介/主要調查結果
  • 過去的市場規模(10億美元)分析:各適應症，2019年～2023年
  • 現在及未來市場規模(10億美元)的分析與預測:各適應症，2024年～2033年
    • 重度的主動脈閥狹窄症
    • 閥門界內閥門手術(生物學心臟瓣膜不全)
    • 主動脈閥逆流症
  • 市場魅力分析:各適應症

第10章 全球市場分析:各終端用戶

  • 簡介/主要調查結果
  • 過去的市場規模(10億美元)分析:各終端用戶，2019年～2023年
  • 現在及未來市場規模(10億美元)的分析與預測:各終端用戶，2024年～2033年
    • 醫院
    • 獨立了的心導管檢驗室
    • 門診病人手術中心
  • 市場魅力分析:各終端用戶

第11章 全球市場分析:各地區

  • 簡介
  • 過去的市場規模(10億美元)的分析:各地區，2019年～2023年
  • 現在及未來市場規模(10億美元)的分析與預測:各地區，2024年～2033年
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東·非洲(MEA)
  • 市場魅力分析:各地區

第12章 北美市場分析

第13章 南美市場分析

第14章 歐洲市場分析

第15章 東亞市場分析

第16章 南亞市場分析

第17章 大洋洲市場

第18章 中東·非洲(MEA)市場分析

第19章 市場結構分析

  • 市場分析:各企業層級
  • 主要企業的市場佔有率分析
  • 市場影響分析

第20章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭的詳細資訊
    • Abbott
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Boston Scientific Corporation
    • JenaValve Technology, Inc.
    • Meril Life Sciences
    • Sahajanand Medical Technologies Limited
    • MicroPort Scientific Corporation
    • Venus Medtech(Hangzhou)Inc.
    • Suzhou Jiecheng Medical Technology Co. Ltd.
    • Peijia Medical Limited
    • Blue Sail Medical Co., Ltd.

第21章 所使用的前提條件與縮寫

第22章 調查手法

簡介目錄
Product Code: PMRREP11167

Persistence Market Research has recently published an in-depth report on the global transcatheter heart valve replacement and repair (TAVR) market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a comprehensive understanding of the market structure and future outlook, particularly for stakeholders in the cardiovascular medical device industry.

Key Insights:

  • Global Market Revenue (2022): US$ 8.4 Billion
  • Estimated Market Value (2033): US$ 25.5 Billion
  • Global Market Growth Rate (CAGR 2022-2033): 13.1%

Global TAVR Market - Report Scope:

The TAVR market focuses on the production and distribution of devices and technologies used in the replacement and repair of heart valves, particularly for patients suffering from severe aortic stenosis and other cardiovascular diseases. This market is driven by the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and continuous technological advancements in TAVR products.

Market Growth Drivers:

Continuous Technological Advancements in TAVR Products Coupled with Increasing Prevalence of Cardiovascular Diseases

One of the primary drivers of the TAVR market is the continuous technological advancements in transcatheter aortic valve replacement (TAVR) devices. Companies are developing second-generation TAVR devices with enhanced durability to reduce immune rejections in patients with severe aortic stenosis. These newer devices offer significant safety benefits, including lower rates of paravalvular regurgitation, valve embolization, and other bleeding events, as evidenced by several recent studies.

Advanced imaging technologies are also playing a crucial role in improving decision-making during TAVR procedures. These innovations are expected to create lucrative opportunities for the market to flourish, with ongoing technological developments driving future growth in TAVI (transcatheter aortic valve implantation) and TAVR products.

The rising prevalence of cardiovascular diseases (CVDs) is another significant factor fueling the growth of the TAVR market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths per year. With heart attacks and strokes making up more than four out of every five CVD deaths, the demand for effective valve replacement surgeries, such as TAVR, is expected to rise, driving market expansion.

Market Challenges:

High Costs and Regulatory Challenges

Despite the promising growth prospects, the TAVR market faces several challenges. The high cost of TAVR procedures and devices can be a significant barrier to widespread adoption, particularly in low- and middle-income countries where healthcare budgets are limited. Additionally, the regulatory landscape for TAVR devices is complex, with stringent approval processes required before new products can be introduced to the market. Navigating these regulatory challenges can be time-consuming and costly, potentially slowing down market growth.

Furthermore, while technological advancements are driving the market forward, they also require substantial investment in research and development. Companies must continuously innovate to stay competitive, which can strain resources and impact profitability, particularly for smaller players in the market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global TAVR market?
  • Which consumer segments are leading the adoption of TAVR procedures?
  • How are technological advancements influencing the competitive landscape?
  • Who are the key players in the global TAVR market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global TAVR market?

Competitive Intelligence and Business Strategy:

Leading players in the global TAVR market, including Edwards Lifesciences, Medtronic, and Boston Scientific Corporation, are focusing on product innovation, strategic partnerships, and expanding their market presence in emerging economies. These companies are heavily investing in research and development to create next-generation TAVR devices that offer improved safety, durability, and patient outcomes. Collaborations with healthcare providers and academic institutions are enhancing market credibility and driving the adoption of new technologies.

Additionally, the market is seeing a trend towards the integration of advanced imaging and diagnostic tools with TAVR procedures, further improving the precision and outcomes of valve replacement surgeries. As the market continues to grow, companies are expected to explore new opportunities in minimally invasive cardiovascular procedures and expand their product portfolios to cater to a broader patient population.

Key Companies Profiled:

  • Abbott
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • JenaValve Technology, Inc.
  • Meril Life Sciences
  • Sahajanand Medical Technologies Limited
  • MicroPort Scientific Corporation
  • Venus Medtech (Hangzhou) Inc.
  • Suzhou Jiecheng Medical Technology Co. Ltd.
  • Peijia Medical Limited
  • Blue Sail Medical Co., Ltd.

Key Segments Covered in Transcatheter Heart Valve Replacement Repair Industry Research

Product:

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Transcatheter Mitral Valve Repair (TMVR)

Indication:

  • Severe Aortic Valve Stenosis
  • Valve-in-Valve Procedures (Failed Bioprosthesis)
  • Aortic Regurgitation

End User:

  • Hospitals
  • Independent Cardiac Catheterization Labs
  • Ambulatory Surgical Centres

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Rate/Usage Analysis - By Region
  • 4.2. Technology Assessment
  • 4.3. Product USP Analysis
  • 4.4. Regulatory Scenario
  • 4.5. Disease Epidemiology
  • 4.6. Reimbursement Landscape
  • 4.7. Recent Product Approvals/Launches
  • 4.8. PESTEL Analysis
  • 4.9. Porter's Analysis
  • 4.10. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Cardiac Surgery Devices Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Cardiovascular Diseases
    • 5.2.2. Demand for Minimally Invasive Procedures
    • 5.2.3. Growing Number of Patients Suffering from Aortic Stenosis
    • 5.2.4. Increasing Product Approvals
    • 5.2.5. Technological Advancements
    • 5.2.6. Prevalence of Obesity
    • 5.2.7. Increasing Surgical Procedural Volume
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Indication
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
    • 8.3.1. Transcatheter Aortic Valve Replacement (TAVR) Devices
      • 8.3.1.1. Self - Expandable Transcatheter Aortic Valves
      • 8.3.1.2. Balloon-Expandable Transcatheter Aortic Valves
      • 8.3.1.3. "Mechanically Expanded Transcatheter Aortic Valves"
    • 8.3.2. Transcatheter Mitral Valve Repair (TMVR) Devices
  • 8.4. Market Attractiveness Analysis, by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Indication, 2024-2033
    • 9.3.1. Severe Aortic Valve Stenosis
    • 9.3.2. Valve-in-Valve Procedures (Failed Bioprosthesis)
    • 9.3.3. Aortic Regurgitation
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Independent Cardiac Catheterization Labs
    • 10.3.3. Ambulatory Surgical Centers
  • 10.4. Market Attractiveness Analysis, by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Indication
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Market Analysis
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.1.2.1. By Product
        • 12.7.1.2.2. By Indication
        • 12.7.1.2.3. By End User
    • 12.7.2. Canada Market Analysis
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.2.2.1. By Product
        • 12.7.2.2.2. By Indication
        • 12.7.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Indication
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Mexico Market Analysis
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.1.2.1. By Product
        • 13.7.1.2.2. By Indication
        • 13.7.1.2.3. By End User
    • 13.7.2. Brazil Market Analysis
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.2.2.1. By Product
        • 13.7.2.2.2. By Indication
        • 13.7.2.2.3. By End User
    • 13.7.3. Argentina Market Analysis
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.3.2.1. By Product
        • 13.7.3.2.2. By Indication
        • 13.7.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Indication
        • 14.7.1.2.3. By End User
    • 14.7.2. Italy Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Indication
        • 14.7.2.2.3. By End User
    • 14.7.3. France Market Analysis
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.3.2.1. By Product
        • 14.7.3.2.2. By Indication
        • 14.7.3.2.3. By End User
    • 14.7.4. U.K. Market Analysis
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.4.2.1. By Product
        • 14.7.4.2.2. By Indication
        • 14.7.4.2.3. By End User
    • 14.7.5. Spain Market Analysis
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.5.2.1. By Product
        • 14.7.5.2.2. By Indication
        • 14.7.5.2.3. By End User
    • 14.7.6. BENELUX Market Analysis
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.6.2.1. By Product
        • 14.7.6.2.2. By Indication
        • 14.7.6.2.3. By End User
    • 14.7.7. Russia Market Analysis
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.7.2.1. By Product
        • 14.7.7.2.2. By Indication
        • 14.7.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Product
    • 15.4.2. By Indication
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. China Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Indication
        • 15.7.1.2.3. By End User
    • 15.7.2. Japan Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Indication
        • 15.7.2.2.3. By End User
    • 15.7.3. South Korea Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Indication
        • 15.7.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. India Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Indication
        • 16.7.1.2.3. By End User
    • 16.7.2. Indonesia Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Indication
        • 16.7.2.2.3. By End User
    • 16.7.3. Malaysia Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Indication
        • 16.7.3.2.3. By End User
    • 16.7.4. Thailand Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Product
        • 16.7.4.2.2. By Indication
        • 16.7.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Indication
        • 17.7.1.2.3. By End User
    • 17.7.2. New Zealand Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Indication
        • 17.7.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Indication
    • 18.4.3. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Indication
        • 18.7.1.2.3. By End User
    • 18.7.2. Turkiye Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Indication
        • 18.7.2.2.3. By End User
    • 18.7.3. South Africa Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Indication
        • 18.7.3.2.3. By End User
    • 18.7.4. North Africa Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Product
        • 18.7.4.2.2. By Indication
        • 18.7.4.2.3. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Abbott
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Product Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. Edwards Lifesciences Corporation
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Product Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Medtronic plc
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Product Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Boston Scientific Corporation
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Product Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. JenaValve Technology, Inc.
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Product Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. Meril Life Sciences
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Product Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. Sahajanand Medical Technologies Limited
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Product Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. MicroPort Scientific Corporation
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Product Strategy
        • 20.3.8.6.3. Channel Strategy
    • 20.3.9. Venus Medtech (Hangzhou) Inc.
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Marketing Strategy
        • 20.3.9.6.2. Product Strategy
        • 20.3.9.6.3. Channel Strategy
    • 20.3.10. Suzhou Jiecheng Medical Technology Co. Ltd.
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Marketing Strategy
        • 20.3.10.6.2. Product Strategy
        • 20.3.10.6.3. Channel Strategy
    • 20.3.11. Peijia Medical Limited
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Key Financials
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategy Overview
        • 20.3.11.6.1. Marketing Strategy
        • 20.3.11.6.2. Product Strategy
        • 20.3.11.6.3. Channel Strategy
    • 20.3.12. Blue Sail Medical Co., Ltd.
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Sales Footprint
      • 20.3.12.4. Key Financials
      • 20.3.12.5. SWOT Analysis
      • 20.3.12.6. Strategy Overview
        • 20.3.12.6.1. Marketing Strategy
        • 20.3.12.6.2. Product Strategy
        • 20.3.12.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology